new_0222_0342|EWTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0342|EWTX|1|Edgewise Therapeutics Inc Total Current Assets (Quarterly) (USD)|Edgewise Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Edgewise Therapeutics Inc Inventories (Quarterly) (USD)|Edgewise Therapeutics Inc Net PP&E (Quarterly) (USD)|Edgewise Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Edgewise Therapeutics Inc Total Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Edgewise Therapeutics Inc Total Deposits (Quarterly) (USD)|Edgewise Therapeutics Inc Book Value (Quarterly) (USD)|Edgewise Therapeutics Inc Retained Earnings (Quarterly) (USD)|Edgewise Therapeutics Inc Treasury Stock (Quarterly) (USD)|Edgewise Therapeutics Inc EV to Revenues|Edgewise Therapeutics Inc EV to Earnings|Edgewise Therapeutics Inc EV to Free Cash Flow|Edgewise Therapeutics Inc EV to Assets (Quarterly)|Edgewise Therapeutics Inc PS Ratio|Edgewise Therapeutics Inc PE Ratio|Edgewise Therapeutics Inc Price to Book Value|Edgewise Therapeutics Inc PEG Ratio|Edgewise Therapeutics Inc Debt to Equity Ratio|Edgewise Therapeutics Inc Dividend Yield|Edgewise Therapeutics Inc Shareholder Yield (TTM)|Edgewise Therapeutics Inc Percent of Shares Outstanding Short|Edgewise Therapeutics Inc Total Receivables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Payables (Quarterly) (USD)|Edgewise Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Return on Invested Capital|Edgewise Therapeutics Inc Quality Ratio Score|Edgewise Therapeutics Inc Momentum Score|Edgewise Therapeutics Inc Beta (1Y)|Edgewise Therapeutics Inc Sustainable Growth Rate (TTM)|Edgewise Therapeutics Inc Institutional Investor Ownership Percentage|Edgewise Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Edgewise Therapeutics Inc Total Employees (Annual)|Edgewise Therapeutics Inc EPS Diluted (Quarterly) (USD)|Edgewise Therapeutics Inc SG&A Expense (Quarterly) (USD)|Edgewise Therapeutics Inc Shares Outstanding|Edgewise Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Edgewise Therapeutics Inc Ordinary Shares Number (Quarterly)|Edgewise Therapeutics Inc Payout Ratio|Edgewise Therapeutics Inc Quick Ratio (Quarterly)|Edgewise Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Edgewise Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Edgewise Therapeutics Inc Effective Tax Rate (TTM)|Edgewise Therapeutics Inc Return on Equity|Edgewise Therapeutics Inc Net Income (TTM) (USD)|Edgewise Therapeutics Inc Revenue (TTM) (USD)|Edgewise Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Edgewise Therapeutics Inc Revenue (Quarterly) (USD)|Edgewise Therapeutics Inc Gross Profit (Quarterly) (USD)|Edgewise Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Income (Quarterly) (USD)|Edgewise Therapeutics Inc Net Interest Income (Quarterly) (USD)|Edgewise Therapeutics Inc Price (USD)|Edgewise Therapeutics Inc Total Return Price (USD)|Edgewise Therapeutics Inc Enterprise Value (USD)|Edgewise Therapeutics Inc 30-Day Average Daily Volume|Edgewise Therapeutics Inc 1 Year Price Returns (Daily)|Edgewise Therapeutics Inc Short Interest|Edgewise Therapeutics Inc PE Ratio (Forward)|Edgewise Therapeutics Inc PE Ratio (Forward 1y)|Edgewise Therapeutics Inc PS Ratio (Forward)|Edgewise Therapeutics Inc PS Ratio (Forward 1y)|Edgewise Therapeutics Inc Quarterly EPS Estimates (USD)|Edgewise Therapeutics Inc Quarterly Revenue Estimates (USD)|Edgewise Therapeutics Inc Quarterly EPS Surprise|Edgewise Therapeutics Inc Quarterly Revenue Surprise|Edgewise Therapeutics Inc Quarterly Actual EPS (USD)|Edgewise Therapeutics Inc Quarterly Actual Revenue (USD)|Edgewise Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Edgewise Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Edgewise Therapeutics Inc Price Target (USD)|Edgewise Therapeutics Inc Consensus Recommendation|Edgewise Therapeutics Inc Price Target Num Estimates|Edgewise Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Edgewise Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Edgewise Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Edgewise Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Edgewise Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Edgewise Therapeutics Inc Land and Improvements (Quarterly) (USD)|Edgewise Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Edgewise Therapeutics Inc Other Properties (Quarterly) (USD)|Edgewise Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0342|EWTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0342|EWTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0342|EWTX|5|91|91||91||91|91|91||91|91||||1.44298245614||||1.44|||1.44298245614||15.3||91|91|||||||91.3333333333|91|91.3333333333|91.3333333333|27.875||91|||91.3333333333|91.3333333333|||91|||||91.3333333333|91.3333333333|91.3333333333|1.44298245614|1.44298245614|1.44298245614|1.44221105528||15.3|||||91.4285714286|91.4285714286|91.5||91.5|91.5|37.5|42.8571428571|18.9375|12.625|18.9375|21.5|23.1538461538|91.3333333333|91.3333333333|||||||
new_0222_0342|EWTX|6|3|3||3||3|3|3||3|3||||228||||225|||228||20||3|3|||||||6|3|6|6|8||3|||6|6|||3|||||6|6|6|228|228|228|199||20|||||7|7|2||2|2|8|7|16|24|16|14|13|6|6|||||||
new_0222_0342|EWTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0342|EWTX|202003||||||||||||||||||||||||||||||||||20.3381||-0.1566|0.281||||||-0.1566|||||||||-3.185|-3.185|0.063||||||||||||||||||||||||2.967|0.04|||||||
new_0222_0342|EWTX|202006||||||||||||||||||||||||||||||||||20.3381||-0.1944|0.318||||||-0.1944|||||||||-3.954|-3.954|0.003||||||||||||||||||||||||3.639|0.045|||||||
new_0222_0342|EWTX|202009||||||||||||||||||||||||||||||||||20.3381||-0.1791|0.405||||||-0.1791|||||||||-3.642|-3.642|0.001||||||||||||||||||||||||3.238|0.05|||||||
new_0222_0342|EWTX|202012|129.645|129.094||0.516||164.556|4.342|160.214||-33.42|-34.147|||||||||||||||1.58||||||||46.567|19|-0.1362|1.205|||49.262|||-0.1362||||-17.123|||||-6.342|-6.342|0.002||||||||||||||||||||||||5.139|0.05|||||||
new_0222_0342|EWTX|202103|310.545|309.871||0.499||4.851|4.851|||306.394|-40.962||||-70.8971||||5.2245|||||1.0864||1.621|0.005|||||||1.5599|22|-4.37|1.497|49.2543||49.2543|||-4.37|-187.051|||-20.753|||||-6.815|-6.815|0.042|32.5|32.5|1290.8938|134401.0333||535098|||||-0.1516||7.6517||-0.14||||34.25|1.75|4|-0.7244|-1.0212|5.36|0.079||||||28.64|28.87
new_0222_0342|EWTX|202106|302.969|299.151||0.524||6.739|6.739|||296.749|-51.315||||-31.4746||||3.5409|||||3.9577||2.816|0.005|||||||49.2584|26|-0.21|2.599|49.262||49.262|||-0.21|0.903|||-27.152|||||-10.353|-10.353|0.107|21.33|21.33|751.6125|266735.0667||1949634|||||-0.1714||-22.549||-0.21||||31.75|1.75|4|-0.9815|-1.1249|7.861|0.051||||||17.51|15.84
new_0222_0342|EWTX|202109|293.242|290.484||0.911||9.049|8.754|0.295||285.399|-64.264||||-18.0053||||2.8672|||||3.2113||2.292|0.005|||||||49.2649|30|-0.26|3.196|49.2958||49.2958|||-0.26||||-36.459|||||-12.949|-12.949|0.127|16.6|16.6|527.8263|64083.2333||1583023|||||-0.2436||-6.7192||-0.26||||33.3333|1.3333|3|-1.1429|-1.0699|9.88|0.064||||||16.5|17.42
new_0222_0342|EWTX|202112|||||||||||||||-15.7856||||2.6393|||||7.1118|||||||||||||||||||||||||||||||15.28|15.28|462.7558|378933.8333||3505832|||||-0.2582||||||||31.6667|1.3333|3|-1.0861|-1.62||||||||13.6|11.63
new_0222_0342|EWTX|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.31|||||||||||||||||||||
new_0222_0342|EWTX|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.3433|||||||||||||||||||||
new_0222_0342|EWTX|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.38|||||||||||||||||||||
new_0222_0342|EWTX|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.48|||||||||||||||||||||